LUIS HENRIQUE WOLFF GOWDAK

(Fonte: Lattes)
Índice h a partir de 2011
14
Lattes
ResearcherID
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/13 - Laboratório de Genética e Cardiologia Molecular, Hospital das Clínicas, Faculdade de Medicina

Filtros

Limpar filtros

Configurações

Tipo de produção: conferenceObject ×

Resultados de Busca

Agora exibindo 1 - 10 de 21
  • conferenceObject
    CORONARY ASSESSMENT IN YOUNG PATIENTS ON HEMODIALYSIS
    (2020) LIMA, Jose De; GOWDAK, Luis Henrique W.; PAULA, Flavio J. de; DAVID NETO, Elias; BORTOLOTTO, Luiz A.
  • conferenceObject
    Impact of Coronary Atherosclerotic Burden on the Long-Term Prognosis of Patients With Chronic Kidney Disease Undergoing Renal Replacement Therapy
    (2023) GODINHO, Roger; CAMPOS, Carlos; ABIZAID, Alexandre; LIMA, Jose Jayme de; RIBEIRO, Henrique; LOPES, Neuza; MOTA, Gabriel; SANTOS, Luciano; GOWDAK, Luis; KALIL FILHO, Roberto; RIBEIRO, Expedito
  • conferenceObject
    Obstructive Sleep Apnea Is Extremely Common And Associated With Myocardial Ischemia In Patients With Refractory Angina
    (2014) GEOVANINI, G. R.; PEREIRA, A. C.; GOWDAK, L. H. W.; DOURADO, L. O.; POPPI, N.; CESAR, L. M.; DRAGER, L. F.; LORENZI-FILHO, G.
  • conferenceObject
    Cardiac scintigraphy fails to identify patients with single-vessel coronary artery disease and end-stage renal disease: potential impact on cardiovascular morbidity
    (2012) GOWDAK, Luis Henrique W.; PAULA, Flavio J. de; CESAR, Luiz Antonio M.; LIMA, Jose Jayme G. de
    Introduction: Patients (pt) with end-stage renal disease (ESRD) are at increased risk for CAD and major adverse cardiovascular events. Cardiac scintigraphy is regarded as a non-invasive, useful screening tool for risk stratification and to exclude significant CAD in the general population; invasive coronary angiography is usually performed following a positive result in the non-invasive assessment. Objectives: To determine the accuracy of such approach in pt with ESRD being considered as renal transplant candidates. Methods: 482 pt with ESRD (56 ±9 years; 69% men) underwent cardiac scintigraphy (99mTc MIBI-SPECT with dipyridamole) and coronary angiography, regardless of symptoms. Myocardial perfusion scans were categorized as normal or abnormal (fixed and/or transient perfusion defects); significant CAD was defined by luminal stenosis ≥70%. The sensitivity (Sen), specificity (Spe), positive (PPV) and negative (NPV) predictive values were calculated for pt with 1-, 2- or 3-vessel CAD. Kaplan-Meier curves were constructed for the probability of survival free of fatal/non-fatal MACE during a 5-year follow-up based on the results of angiography. Results: 240 pt (50%) had perfusion defects; 237 pt (49%) had significant CAD, of which 89 (38%), 70 (29%), and 78 (33%) had 1-, 2-, and 3-vessel disease, respectively. Figure 1 shows that pt with any degree of significant CAD had a worse-long term prognosis than pt with no CAD. Figure 2 shows that abnormal myocardial scans were more likely to be found in pt with 2- (69%) or 3-vessel CAD (76%), whereas in pt with no CAD, 64% of them had a normal perfusion scan (P<0.0001). However, in pt with 1-vessel CAD, the occurrence of normal and abnormal scans was almost identical (48 vs. 52%). A myocardial perfusion defect yielded a Sen=52%, 69% and 76%, a Spe=28%, 37% and 41%, a PPV=30%, 31% and 39%, and a NPV = 49%, 74% and 77% for the diagnosis of 1-, 2- and 3-vessel CAD, respectively. Conclusion: In pt with ESRD: 1) the prevalence of significant CAD is high, and this imposes a worse long-term prognosis independently of the number of affected vessels; 2) myocardial perfusion assessment by SPECT has a low sensitivity to detect 1-vessel CAD; 3) as a consequence, many pt with 1-vessel CAD could be mistakenly deemed to be free of CAD and, therefore, not treated accordingly, although their long-term prognosis seemed to be no different of that from pt with 2- or 3-vessel disease.
  • conferenceObject
    Cardiac rehabilitation in patients with refractory angina: preliminary results
    (2019) DOURADO, L.; ASSUMPCAO, C. R. A. A.; JORDAO, C. P.; VIEIRA, M. L. C.; GOWDAK, L. H. W.; CESAR, L. A. M.; MATOS, L. D. N. J.
  • conferenceObject
    Obstructive Sleep Apnea In The Spectrum Of Coronary Artery Disease: Stable Versus Refractory Angina Patients
    (2013) GEOVANINI, G. R.; DANZI-SOARES, N.; DOURADO, L. O. C.; POPPI, N. T.; PEREIRA, A. C.; GOWDAK, L. W.; DRAGER, L. F.; LORENZI-FILHO, G.
  • conferenceObject
    Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study
    (2023) GOWDAK, L. Wolff; DOURADO, P.; PRECOMA, D.; DUSILEK, C.; SILVA, F.; YUGAR-TOLEDO, J.; PENA, F.; GOMES, D.; CESTARIO, E.; GUIMARAES JR., O.; HOFFMANN FILHO, C.; ALMEIDA, C.; BRITO, F.; MARTINS, G.; FERREIRA, V.
  • conferenceObject
    COMPLICATIONS AFTER CORONARY ARTERY BYPASS SURGERY: IS THERE A ROLE FOR NONINVASIVE TESTING BEFORE SURGERY?
    (2015) GOWDAK, Luis; FERNANDES, Felipe; VIANNA, Caio; DALLAN, Luis; CESAR, Luiz Antonio M.
  • conferenceObject
    Clinical impact of medical intensive treatment on functional class in patients initially diagnosed as refractory angina
    (2012) DOURADO, Luciana O. C.; POPPI, Nilson T.; PEREIRA, Alexandre C.; CESAR, Luiz Antonio M.; GOWDAK, Luis Henrique W.
    Introduction: Refractory angina is a major clinical challenge. Patients (pt) usually have significant functional impairment due to disabling symptoms, which greatly adversely impact their quality of life. Many pt may be erroneously diagnosed as refractory angina, if not on intensive medical therapy. Objectives: To evaluate the impact of intensive medical treatment on angina functional class in pt initially diagnosed as refractory angina. Methods: 45 pt (31 men, 59±13 years) were included based on the following criteria: 1) disabling symptoms; 2) objectively documented myocardial ischemia; 3) coronary anatomy unsuitable for myocardial revascularization procedures. Medical visits were scheduled every 4 weeks during a 3-month period (Vo to V3). Angina functional class was recorded in each visit as proposed by the Canadian Cardiovascular Society (CCS). Medical therapy was strongly encouraged to be optimized based on patient’s tolerance. Statistical analysis included the Student s t-test (continuous variables), the chi-square test (categorical variables), and the Wilcoxon test (changes in functional class). Results: There was an overall improvement in CCS class between V0 to V3 (p,<0,001), with 30 pt (66.7%) improving at least 1 class. In 14 pt (31.1%) there was no difference and in only 1 pt (2.2%) there was worsening of CCS class. In V0 and V3, anti-ischemic drugs were used as follows (%), respectively: beta-blockers (96 vs. 96), calcium channel blockers (78 vs. 84), long-acting nitrates (96 vs. 100), and trimetazidine (38 vs. 93). Mean daily dosages (mg)of selected drugs were: atenolol 105±49 to 113±59 (P=0.16); carvedilol 44±16 to 55±20 (P=0.06); amlodipine 7±3 to 8±3(P=0.12); isossorbide 95±28 to 106±24(P=0.09). There was a non-significant 4.4% decrease in the mean heart rate (bpm) from 66±11 to 63±9(P=0.10), and a non-significant 4% reduction in mean systolic (SBP) and diastolic (DBP) blood pressure: SBP - 128±23 to 123±23mmHg (P=0.10), and DBP -75±11 to 72±14mmHg (P=0.11). Conclusion: Pt enrolled in this clinical program, although initially diagnosed as refractory angina, experienced a significant improvement in their functional class. This could not be attributed to an increase in anti-ischemic drugs or to an hemodynamic effect. We believe that the regular visits at shorter intervals may have led to a better treatment adherence, emotional easiness and self-confidence. This study exemplifies how complex is the relationship between extensiveness of the disease and functional impairment.
  • conferenceObject
    DIABETES AND CARDIOVASCULAR DISEASE ARE EQUALLY STRONG PREDICTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH END-STAGE RENAL DISEASE
    (2014) GOWDAK, Luis Henrique Wolff; PAULA, Flavio de; CESAR, Luiz Antonio Machado; LIMA, Jose Jayme G. De